Skip Navigation

VAERS Bibliography - May 2002

  1. From the Centers for Disease Control and Prevention. Availability of continuing education CD-ROM program on strategies to increase adult vaccination rates.  JAMA. 2002 Apr 10;287(14):1798. 

  2. Flu-Vaccination. At-risk will get jab for 'silent assassin'.  Nurs Times. 2001 Oct 4-10;97(40):6.

  3. Flu vaccination boost.  Nurs Stand. 2000 May 31-Jun 6;14(37):5.

  4. Allsup, S.J., Gosney, M.A.  Difficulties of recruitment for a randomized controlled trial involving influenza vaccination in healthy older people.  Gerontology. 2002 May-Jun;48(3):170-3.

  5. Alm, J.S., Sanjeevi, C.B., Miller, E.N., Dabadghao, P., Lilja, G., Pershagen, G., Blackwell, J.M., Scheynius, A.  Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471.  Genes Immun. 2002 Apr;3(2):71-7.

  6. Alpay, H., Yildiz, N., Onar, A., Temizer, H., Ozcay, S.  Varicella vaccination in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2002 Mar;17(3):181-3.

  7. Baleta, A.  "Urgent global response" needed to vaccinate the world's children. Lancet. 2002 Apr 20;359(9315):1414. No abstract available.

  8. Baxby, D.  Smallpox vaccination techniques; from knives and forks to needles and pins. Vaccine. 2002 May 15;20(16):2140-9.

  9. Black, G.F., Weir, R.E., Floyd, S., Bliss, L., Warndorff, D.K., Crampin, A.C., Ngwira, B., Sichali, L., Nazareth, B., Blackwell, J.M., Branson, K., Chaguluka, S.D., Donovan, L., Jarman, E., King, E., Fine, P.E., Dockrell, H.M.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.  Lancet. 2002 Apr 20;359(9315):1393-401.

  10. Burton, A.  Vaccine vanquishes varicella.  Lancet. 2002 Apr 20;359(9315):1393-401.

  11. Cook, I.F., Murtagh, J.  Needle length required for intramuscular vaccination of infants and toddlers. An ultrasonographic study.  Aust Fam Physician. 2002 Mar;31(3):295-7.

  12. De Wals, P., Allard, M.A., Guindon, K., Mayrand, L., Simard, S., Black, R.  [Is vaccination against meningitis useful? The findings of an investigation in the Sherbrooke region, Quebec.]  Can Commun Dis Rep. 2002 Apr 15;28(8):61-3.

  13. Froome, J., Badcock, K.  Should vaccination be compulsory for all preschool children?  Nurs Times. 2002 Mar 21-27;98(12):16.

  14. Grossl, N.A. The reluctant acceptance of new ideas in medicine.  Pharos Alpha Omega Alpha Honor Med Soc. 2002 Winter;65(1):18-22.

  15. Habeck, M.  Staphylococcal vaccine one step closer to reality.  Lancet Infect Dis 2002 Apr;2(4):201

  16. Isa, M.B., Martinez, L., Giordano, M., Passeggi, C,. De Wolff M.C., Nates S.  Comparison of Immunoglobulin G Subclass Profiles Induced by Measles Virus in Vaccinated and Naturally Infected Individuals.  Clin Diagn Lab Immunol 2002 May;9(3):693-697

  17. Itoh, M., Okuno, Y., Hotta, H.  Comparative Analysis of Titers of Antibody against Measles Virus in Sera of Vaccinated and Naturally Infected Japanese Individuals of Different Age Groups.  J Clin Microbiol. 2002 May;40(5):1733-1738.

  18. Jha, N., Kannan, A.T., Paudel, I.S., Niraula, S.  EPI vaccination in Nepal.  Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):547-52.

  19. K secik, M., Emiroglu, H., Tatli, M.M., Koc, A., Atas, A.  Prevalence of Tuberculous Infection and the Impact of BCG Vaccination on Tuberculin Testing Among Primary Schoolchildren in Turkey.  Indian Pediatr. 2002 Apr;39(4):362-5.

  20. Kalinowski, P.  The influence of prophylactic vaccination on epidemic situation of infectious diseases illustrated by the epidemiology of measles in Poland in the years 1968-1998.  Ann Univ Mariae Curie Sklodowska [Med]. 2001;56:327-32.

  21. Kapikian, A.Z.  Ecological studies, rotavirus vaccination, and intussusception.  Lancet. 2002 Mar 23;359(9311):1065-6; discussion 1066.

  22. Karim, Y., Masood, A. Haemolytic uraemic syndrome following mumps, measles, and rubella vaccination. Nephrol Dial Transplant. 2002 May;17(5):941-2.

  23. Katona, S.J. Vaccination to prevent varicella and shingles.   J Clin Pathol 2002 May;55(5):399 Katz, S.L.   Measles prevention-- just vaccinate.  J Pediatr. 2002 Mar;140(3):382; discussion 382.

  24. Kelly, H.A., Riddell, M.A., Andrews, R.M.  Measles transmission in healthcare settings in Australia.  Med J Aust. 2002 Jan 21;176(2):50-1.

  25. Kribs-Zaleta, C.M., Martcheva, M.  Vaccination strategies and backward bifurcation in an age-since-infection structured model.  Math Biosci. 2002 May-Jun;177-178:317-32.

  26. Mahony, C.  Vaccination. Nurse anxiety after GMC charges doctor over single-dose MMR jabs.  Nurs Times. 2001 Aug 16-22;97(33):9.

  27. Marshall, B.C., Henshaw, C., Evans, D.A., Bleyl, K., Alder, S., T.G.  Influenza vaccination coverage level at a cystic fibrosis center.  Pediatrics 2002 May;109(5):E80-0

  28. Matsui, M., Kawano, H., Matsukura, M., Otani, Y., Miike, T.  Acute transverse myelitis after Japanese B encephalitis vaccination in a 4-year-old girl.  Brain Dev. 2002 Apr;24(3):187-9.

  29. Moreton, J.  Childhood vaccination programmes: what's new?  Community Nurse 2000 Oct;6(9):47-9

  30. Nicol, M., Eley, B., Kibel, M., Hussey, G.  Intradermal BCG vaccination--adverse reactions and their management.  S Afr Med J. 2002 Jan;92(1):39-42. Review.

  31. Postma, M.J., Jansema, P., Van Genugten, M.L., Heijnen, M.L., Jager, J.C., De Jong-Van Den Berg, L.T.  Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.  Drugs 2002;62(7):1013-24

  32. Quirk, M.  Home-grown Vietnamese cholera vaccine "completely safe".  Lancet Infect Dis 2002 Apr;2(4):198

  33. Salgado, C.D., Farr, B.M., Hall, K.K., Hayden, F.G. Influenza in the acute hospital setting.  Lancet Infect Dis 2002 Mar;2(3):145-55

  34. Simonsen, L., Morens, D.M., Blackwelder, W.C.  Ecological studies, rotavirus vaccination, and intussusception.  Lancet. 2002 Mar 23;359(9311):1066-7; discussion 1066.

  35. Terada, K., Niizuma, T., Ogita, S., Kataoka, N.  [Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan]  Kansenshogaku Zasshi. 2002 Mar;76(3):180-4. Japanese.

  36. Traynor, K.  Groups revise general vaccination recommendations.  Am J Health Syst Pharm. 2002 Apr 1;59(7):598.

  37. Trotter, C.L., Edmunds, W.J.  Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002 Apr 6;324(7341):809.

  38. Umeed, M.  Vaccinating against influenza and pneumococcus.  Nurs Times. 2001 Oct 18-24;97(42):32-4.

  39. Virk, G.  Keep an open mind on MMR vaccination.  Nurs Stand 2002 Apr 10-16;16(30):25

  40. Wilder-Smith, A., Paton, N.I.  Crossover Vaccination with Quadrivalent Meningococcal Vaccine (against A/C/Y/W-135) Following Recent Application of Bivalent Meningococcal Vaccine (against A/C): Assessment of Safety and Side Effect Profile.  J Travel Med. 2002 Jan-Feb;9(1):20-3.

  41. Wilton, P., Smith, R., Coast, J., Millar, M.  Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness.  J Health Serv Res Policy 2002 Apr;7(2):111-7.

[top]